| scholarly article | Q13442814 |
| P2093 | author name string | Eric M Smith | |
| P2860 | cites work | Corticotropin-releasing factor binding to peripheral tissue and activation of the adenylate cyclase-adenosine 3',5'-monophosphate system | Q70085522 |
| A potential role for adrenocorticotropin in regulating human B lymphocyte functions | Q70110224 | ||
| Regulation of lymphokine (gamma-interferon) production by corticotropin | Q70180739 | ||
| Corticotropin-releasing factor-induced production of cyclic AMP by human peripheral blood immunocytes | Q70460674 | ||
| Analysis of proopiomelanocortin (POMC) messenger ribonucleic acid and POMC-derived peptides in human peripheral blood mononuclear cells: no evidence for a lymphocyte-derived POMC system | Q70492674 | ||
| Adrenocorticotropin--a central trigger in immune responsiveness: tonal inhibition of immune activation | Q71336038 | ||
| Changes in ACTH and beta-endorphin immunoreactivity in immune tissues during a chronic inflammatory stress are not correlated with changes in corticotropin-releasing hormone and arginine vasopressin | Q71977740 | ||
| The hormonal nature of the interferon system | Q72685390 | ||
| Endorphins stimulate normal human peripheral blood lymphocyte natural killer activity | Q72736917 | ||
| Effects of a chronic inflammatory stress on levels of pro-opiomelanocortin-derived peptides in the rat spleen and thymus | Q72740259 | ||
| Suppression of in vitro antibody production by corticotropin-releasing factor neurohormone | Q72830947 | ||
| Mitogen-stimulated lymphocytes release biologically active corticotropin | Q72951919 | ||
| An antisense oligodeoxynucleotide complementary to corticotropin-releasing hormone mRNA inhibits rat splenocyte proliferation in vitro | Q73323443 | ||
| Corticotropin-releasing hormone acts on immune cells to elicit pro-inflammatory responses | Q73759541 | ||
| Production of peptide hormones and neurotransmitters by the immune system | Q73837325 | ||
| Effects of interleukin-2 on the expression of corticotropin-releasing hormone in nerves and lymphoid cells in secondary lymphoid organs from the Fischer 344 rat | Q74431936 | ||
| Corticotropin-releasing factor receptor 1 in mouse spleen: expression after immune stimulation and identification of receptor-bearing cells | Q74595924 | ||
| Urocortin 1 and Urocortin 2 induce macrophage apoptosis via CRFR2 | Q80959647 | ||
| Corticotropin Releasing Factor (CRF) activation of NF-kappaB-directed transcription in leukocytes | Q28236185 | ||
| Human lymphocytes produce urocortin, but not corticotropin-releasing hormone | Q28262079 | ||
| Function and activation of NF-kappa B in the immune system | Q29547790 | ||
| Mechanisms of antiinflammatory action of alpha-MSH peptides. In vivo and in vitro evidence. | Q33921658 | ||
| The CRF peptide family and their receptors: yet more partners discovered | Q34112872 | ||
| Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells | Q34144521 | ||
| The physiology of corticotropin-releasing hormone deficiency in mice | Q34241354 | ||
| CRH in chronic inflammatory stress | Q34241410 | ||
| Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response | Q34241415 | ||
| Purification and characterization of a paired basic residue-specific pro-opiomelanocortin converting enzyme from bovine pituitary intermediate lobe secretory vesicles. | Q34564290 | ||
| Expression of pro-opiomelanocortin gene and quantification of adrenocorticotropic hormone-like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies. | Q34567385 | ||
| Opioid peptides in immune cells. | Q35078229 | ||
| Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue | Q35221862 | ||
| Regulation of the in vitro antibody response by neuroendocrine hormones | Q36302681 | ||
| Human lymphocyte production of corticotropin and endorphin-like substances: association with leukocyte interferon | Q36383046 | ||
| Corticotropin-releasing hormone deficiency unmasks the proinflammatory effect of epinephrine | Q36393230 | ||
| Human leukocyte interferon: structural and biological relatedness to adrenocorticotropic hormone and endorphins | Q36410910 | ||
| Corticotropin-releasing factor mRNA in rat thymus and spleen | Q36450969 | ||
| Immunosuppressive effects of corticotropin and melanotropin and their possible significance in human immunodeficiency virus infection | Q36799869 | ||
| Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages | Q36994028 | ||
| Bacterial lipopolysaccharide induction of leukocyte-derived corticotropin and endorphins | Q37034167 | ||
| GH3 pituitary adenoma cells can reverse thymic aging in rats | Q37392980 | ||
| Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia | Q37573891 | ||
| Nucleotide and amino acid sequence of lymphocyte-derived corticotropin: endotoxin induction of a truncated peptide | Q37685623 | ||
| Human lymphocyte production of immunoreactive thyrotropin | Q37690221 | ||
| mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues | Q38310072 | ||
| Regulation of nuclear factor-kappaB by corticotropin-releasing hormone in mouse thymocytes | Q38361525 | ||
| Regulation of production of adrenocorticotropin-like proteins in human mononuclear cells | Q39227796 | ||
| Physiological Functions of Glucocorticoids in Stress and Their Relation to Pharmacological Actions* | Q40172536 | ||
| Effects of corticotropin-releasing hormone (CRH) on monocyte function, mediated by CRH-receptor subtype R1 and R2: a potential link between mood disorders and endothelial dysfunction? | Q40327218 | ||
| Corticotropin-releasing factor and the urocortins induce the expression of TLR4 in macrophages via activation of the transcription factors PU.1 and AP-1. | Q40327323 | ||
| Beta-endorphin secretion by human peripheral blood mononuclear cells: regulation by glucocorticoids | Q68417430 | ||
| Role of growth hormone in regulating T-dependent immune events in aged, nude, and transgenic rodents | Q68833225 | ||
| In vivo immunoreactive adrenocorticotropin (ACTH) production by human mononuclear leukocytes from normal and ACTH-deficient individuals | Q68978762 | ||
| Use of peptides encoded by complementary RNA for generating anti-idiotypic antibodies of predefined specificity | Q69122001 | ||
| Corticotropin (ACTH) induction of tumor necrosis factor alpha by monocytes | Q69365678 | ||
| Immunoregulatory effects of alpha-endorphin, beta-endorphin, methionine-enkephalin, and adrenocorticotropic hormone on anti-tetanus toxoid antibody synthesis by human lymphocytes | Q69372523 | ||
| Stimulatory effect of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression | Q69742012 | ||
| Ability of corticotropin releasing hormone to stimulate cortisol secretion independent from pituitary adrenocorticotropin | Q69817184 | ||
| Binding of [125I]corticotropin releasing factor to blood immunocytes and its reduction in Alzheimer's disease | Q69829052 | ||
| Stress-induced changes in corticotropin-releasing factor (CRF) in immune tissues and hypothalamus: studies toward defining a role for CRF in neuroimmunomodulation | Q69854513 | ||
| Signaling pathway-related gene expression in neuroimmunoregulation | Q40596171 | ||
| Human immunodeficiency virus induction of corticotropin in lymphoid cells | Q40988799 | ||
| alpha-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line | Q41234949 | ||
| Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis | Q41283113 | ||
| The relevance of opioids and opioid receptors on immunocompetence and immune homeostasis | Q41293964 | ||
| CRH and the immune system | Q41355419 | ||
| Corticotropin-releasing factor in antinociception and inflammation. | Q41433098 | ||
| Effects of Newcastle disease virus administration to mice on the metabolism of cerebral biogenic amines, plasma corticosterone, and lymphocyte proliferation | Q41449212 | ||
| Common pathways of interferon and hormonal action | Q41642486 | ||
| Modulation of IgM secretion and H chain mRNA expression in CH12.LX.C4.5F5 B cells by adrenocorticotropic hormone | Q41710536 | ||
| Enhancing effect of corticotropin-releasing neurohormone on the production of interleukin-1 and interleukin-2. | Q41710815 | ||
| Corticotropin-releasing factor receptors in mouse spleen: identification of receptor-bearing cells as resident macrophages | Q41729387 | ||
| Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones | Q41967745 | ||
| Ectopic Adrenocorticotropin Production: Disappearance after Removal of Inflammatory Tissue* | Q42453854 | ||
| Central corticotropin-releasing hormone activates the sympathetic nervous system and reduces immune function: increased responsivity of the aged rat. | Q42458480 | ||
| Regulation of adrenal glucocorticoid synthesis by interleukin-10: a preponderance of IL-10 receptor in the adrenal zona fasciculata | Q42485903 | ||
| Pituitary-adrenal axis regulation in CRH-deficient mice | Q42499702 | ||
| The kinetics of ACTH expression in rat leukocyte subpopulations. | Q42513607 | ||
| Newcastle disease virus-infected splenocytes express the proopiomelanocortin gene | Q42792106 | ||
| Immuno-Reactive and Bioactive Corticotropin-Releasing Factor in Rat Thymus | Q43445118 | ||
| Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. | Q43707775 | ||
| Dynorphin, a preferential ligand for kappa-opioid receptors, is present in nerve fibers and immune cells within inflamed tissue of the rat. | Q44332637 | ||
| Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception | Q44333598 | ||
| Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin | Q44337972 | ||
| Local analgesic effect of endogenous opioid peptides | Q44338122 | ||
| Cholecystokinin inhibits peripheral opioid analgesia in inflamed tissue | Q44347929 | ||
| Human lymphocytes produce pro-opiomelanocortin gene-related transcripts. Effects of lymphotropic viruses | Q44974837 | ||
| The role of IL-1 in the corticotropin-releasing factor and arginine- vasopressin-induced secretion of immunoreactive beta-endorphin by human peripheral blood mononuclear cells | Q45027348 | ||
| Virus-induced corticosterone in hypophysectomized mice: a possible lymphoid adrenal axis | Q45805049 | ||
| Central corticotropin-releasing factor suppresses natural killer cytotoxicity. | Q46009403 | ||
| CRF activates autonomic nervous system and reduces natural killer cytotoxicity | Q46258975 | ||
| Stimulation of rat B-lymphocyte proliferation by corticotropin-releasing factor | Q46409186 | ||
| Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes | Q48044189 | ||
| Effects of two neuropeptides, somatoliberin (GRF) and corticoliberin (CRF), on human lymphocyte natural killer activity | Q48106998 | ||
| Corticotropin-releasing factor receptors in mouse spleen: identification, autoradiographic localization, and regulation by divalent cations and guanine nucleotides | Q48120891 | ||
| Modulation of the immune response by POMC-derived peptides. I. Influence on proliferation of human lymphocytes | Q48180380 | ||
| Induction of pituitary sensitivity to interleukin-1: a new function for corticotropin-releasing hormone | Q48188062 | ||
| Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. | Q48193383 | ||
| Response of pituitary and spleen pro-opiomelanocortin mRNA, and spleen and thymus interleukin-1 beta mRNA to adjuvant arthritis in the rat | Q48517484 | ||
| Differential effects of beta-endorphin on cAMP levels in human peripheral blood mononuclear cells | Q48913297 | ||
| Corticotrophin-releasing factor-like immunoreactivity and mRNA in human leukocytes. | Q49068345 | ||
| Induction of beta-endorphin secretion by lymphocytes after subcutaneous administration of corticotropin-releasing factor | Q49124139 | ||
| Adrenocorticotropin (ACTH) functions as a late-acting B cell growth factor and synergizes with interleukin 5. | Q52061373 | ||
| Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. | Q52235332 | ||
| Co-expression of beta-endorphin with adhesion molecules in a model of inflammatory pain. | Q52970900 | ||
| Lymphocytes upregulate signal sequence-encoding proopiomelanocortin mRNA and beta-endorphin during painful inflammation in vivo. | Q54562304 | ||
| Secretion of immunoreactive corticotropin releasing factor and adrenocorticotropic hormone by T- and B-lymphocytes in response to cellular stress factors. | Q54625455 | ||
| Local upregulation of corticotropin-releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation | Q56990798 | ||
| Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need | Q59059897 | ||
| Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins | Q59081573 | ||
| Biosynthesis of corticotropin-releasing hormone in human T-lymphocytes | Q61054361 | ||
| Enhancement of natural cytotoxicity by beta-endorphin | Q67277949 | ||
| Corticotropin-releasing factor-induced immunosuppression in human and invertebrate immunocytes | Q67508122 | ||
| Two Different Signalling Pathways for the Induction of Immunoreactive β-Endorphin Secretion by Human Peripheral Blood Mononuclear Cells | Q67897423 | ||
| Modulation of natural killer cell-mediated lysis by corticotropin-releasing neurohormone | Q67947911 | ||
| Proopiomelanocortin gene expression in a distinct population of rat spleen and lung leukocytes | Q68168524 | ||
| Stimulation of interleukin-6 production by corticotropin-releasing factor | Q68193654 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 3-14 | |
| P577 | publication date | 2007-09-27 | |
| P1433 | published in | Brain, Behavior, and Immunity | Q15716593 |
| P1476 | title | Neuropeptides as signal molecules in common with leukocytes and the hypothalamic-pituitary-adrenal axis | |
| P478 | volume | 22 |
| Q33907129 | A review of metabolic staging in severely injured patients. |
| Q46523965 | Does stress-induced release of interleukin-1 cause liver injury? |
| Q48646630 | Effect of prior stress on interleukin-1β and HPA axis responses to acute stress |
| Q51458568 | Effect of rotation and immobilization stress on IL-1β, IL-2, IL-4, and IFN-γ production by splenocytes under opiate receptor blockade in vivo. |
| Q44349107 | Effects of β-endorphin on functional activity of mouse splenocytes under conditions of in vivo blockade of μ,δ-opioid receptors. |
| Q46493396 | Effects of β-endorphin on the production of reactive oxygen species, IL-1β, Tnf-Α, and IL-10 by murine peritoneal macrophages in vivo |
| Q90589213 | Extra-adrenal glucocorticoid biosynthesis: implications for autoimmune and inflammatory disorders |
| Q48203635 | Inflammatory-linked changes in CpG island methylation of three opioid peptide genes in a rat model for pain. |
| Q37832900 | Interleukin-1 (IL-1) in stress-induced activation of limbic-hypothalamic-pituitary adrenal axis |
| Q54385451 | Mapping the CRF-urocortins system in human osteoarthritic and rheumatoid synovial fibroblasts: effect of vasoactive intestinal peptide. |
| Q37154815 | Surgical inflammation: a pathophysiological rainbow. |
| Q38078558 | Surgical inflammatory stress: the embryo takes hold of the reins again. |
| Q48120538 | Urokinase plasminogen activator system in synovial fibroblasts from osteoarthritis patients: modulation by inflammatory mediators and neuropeptides |
| Q51556457 | β-Endorphin effects on antibody production, proliferation, and secretion of Th1/Th2 cytokines in vivo. |
Search more.